Navigation Links
Malarial gene ascertained,,

Researchers from UK have identified Australian researchers have identified a gene which allows the malaria parasite, Plasmodium falciparum, to develop imperviousness to antimalarial drugs.Plasmodium,is a single-celled organism which is transmitted to humans via the saliva of a biting mosquito, has historically evaded control efforts by building resistance to virtually all of the drugs used to treat malaria.// It is hoped that the new discovery will lead to a new drug that will specifically combat resistance.

Dr Alan Donald, Head of the research team said the finding has been a long time coming. About twelve years ago we discovered this gene and suggested that it might be involved in drug resistance, but another report from another laboratory said that it was not involved. The mutations are in the gene pfmdr1, which encodes for the protein P-glycoprotein homologue 1 (Pgh1). This protein qualifies the parasitic cell to thrive in higher concentrations of antimalarial drugs by stopping the drugs from accruing within the cell.

The mutation helps confer resistance to the drugs mefloquine, quinine, halofantrine, chloroquine, and artemisinin. If a drug can be developed to inhibit the Pgh1 protein, the old drugs would be more effective. However, Dr Donald says other genes also contribute to imperviousness.

"It's clear that there are other genes involved as well. We're in the process of trying to identify the other genes so that we have all the knowledge and can start thinking about developing drugs on a rational basis."

In the shorter term, the discovery will mean existing drugs can be used more carefully. By conducting a genetic survey of the parasite in a particular region, the sensitivity of that population to different drugs can be determined and the drug most likely to be effective can be prescribed.


'"/>




Page: 1

Related medicine news :

1. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
2. Older Malarial Drugs Vs New Ones
3. Death Toll from Malarial Epidemic Raises To 75
4. Malarial Epidemic In Tripura Takes Its Death Toll To 65
5. Bahama’s Malarial Outbreak Need Contro
6. Infants Malarial Risk Lowered by Preventive Measures
7. Clothes Treated with Insecticide Reduces the Risk of Malarial Infection
8. Malarial Deaths on Rise in Assam
9. Malarial Parasite Hides In Placenta
10. New Compound for Anti-Malarial Prophylaxis
11. Controlling Malarial Transmission Not Easy!

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Malarial gene ascertained

(Date:11/27/2009)..., Nov. 27 Shamir Optical...ading provider of innovative products and technolo...that its board of directors had declared a dividen...llion (approximately NIS 37.62 million based on th...e), or approximately US$ 0.609 (approximately NIS ...
(Date:11/27/2009)...Health™ announced today that Spectrum Health...ad Enterprise orthopedic templating solution and i... (PRWEB) November 27, 2009 -- Voyan...th (Grand Rapids, Michigan) has licensed its Traum... its TraumaCad Extend workflow solution, to allow ...
(Date:11/26/2009)...v. 27 The diabetes population in t...25 years and annual medical spending on the diseas...illion today, according to a study published in th... Changing Diabetes ® Program (NCDP), a progr... team from the University of Chicago. ,, Accord...
(Date:11/26/2009)... letters from the North Pole, Textsanta.net lets p... Santa , North Pole, AK (...iciencies at the North Pole Santa Claus has added ...the globe informed of his Christmas progress at th...department have identified a large and growing per...
(Date:11/25/2009)... When most people hear ... a chiropractor can also give patients the help th...int, which is where your jaw (mandible) contacts/c...e most common symptoms associated with TMJ dysfunc... the jaw. But many other symptoms can be caused f...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...logies, Inc. (OTC Bulletin Board: VHGI) the owners...ime Prescription Monitoring System, announced toda...Advisory Board. , Mr. Bocchichio has over 37...t in Charge and Special Agent in Charge in,Miami, ...
...Inc.,(Nasdaq: CADX ) today announced positive to... trial of Acetavance(TM), the company,s intravenou...of acute pain following,abdominal laparoscopic sur...r 24 hours (SPID24) for Acetavance 1000 mg,compare...
...ormation business unit of Cerebrio, LLC, a part of...ternational, Inc. (OTC Bulletin Board: MLKNA), a c...y with applications and services that ease the acc...nique information products and services. , , ...
...ruly safe from extreme heat, weather , , W...rried about being caught up in a killer heat wave ...the South and the Great Plains states, according t...e result of dramatic events such as hurricanes or ...
...t health resource for consumers curbing their spen...EW YORK, Dec. 17 Nearly 40 million U.S. adults de... doctor in the past year because of the cost, acco... service. The study found that women and patients ...
...n (Nasdaq: BPUR ) announced today that it has su...an investigational new drug (IND) application to c...any,s oxygen therapeutic Hemopure(R) [hemoglobin g... chemotherapy in patients with acute myeloid leuke...
Other Medicine News:Health News:VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board 2Health News:Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery 2Health News:Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery 3Health News:Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery 4Health News:Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery 5Health News:Cerebrio, LLC, an Omnicom Group Company, and MedLink International Undertake an Exclusive Development and Marketing Arrangement 2Health News:Nature's Fury Makes South Most Dangerous Area in U.S. 2Health News:Nature's Fury Makes South Most Dangerous Area in U.S. 3Health News:Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions in 2008 2Health News:Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions in 2008 3Health News:Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia 2Health News:Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia 3
(Date:11/25/2009)... Nov. 25 Heska Corporati...anced diagnostic and specialty products to the vet...Roche Diagnostics Corporation for the supply of bl...e veterinary market. ,, (Logo: http://www...., "Heska and Roche share the same passion for inno...
(Date:11/25/2009)...Nov. 25 ERT (Nasdaq: ER..., the Company,s President and CEO, and Keith Schne..., are scheduled to present at the 21st Annual Pipe... December 1, 2009 in New York City, New York. ,...y visiting the Company,s corporate website at htt...
(Date:11/25/2009)...ov. 25 The FDA granted traditional..., a non-nucleoside reverse transcriptase inhibitor... indicated for use in treatment-experienced adults... strains resistant to an NNRTI and other antiretro...ased on 48-week data from two Phase 3 studies know...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Double Recipient Twitters Transplant Olympic Training and Tackles Nursing School 55225 1Double Recipient Twitters Transplant Olympic Training and Tackles Nursing School 55225 2UTSA plant biologists publish where their peers are on the Web 9688 1Introducing anuleaf AD a New FDA Approved Hemorrhoid Treatment 55217 1Introducing anuleaf AD a New FDA Approved Hemorrhoid Treatment 55217 2
... 25 Impact Medical Solutions, Inc. (OTC Bulletin ...ced today that it has commenced a pilot clinical s...nology platform, Muscle Pattern Recognition (MPR)....erns of muscle recruitment and provides detailed... can assist in the diagnosis and treatment of back...
...hopaedic trauma can lead to medical problems for p...VEGAS, Feb. 25 Pregnant women who experience orth...rth and other prenatal complications if they recei... high-risk pregnancies and orthopaedic injuries, a...nual Meeting of the American Academy of Orthopaed...
Other Medicine Technology:Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange 2Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange 3Orthopaedic Injury: High Risk to Pregnant Women 2Orthopaedic Injury: High Risk to Pregnant Women 3
Clear Eye Shield
Vitreoretinal Viscodissector 45 degrees
Subretinal Fluid Cannula
Viscous Infusion Cannula 4mm
Medicine Products: